Daniel van Wamelen, AAN 2019 – Targeting non-motor symptoms in Parkinson’s disease (Part 2)
Daniel van Wamelen (The Maurice Wohl Clinical Neuroscience Institute, King’s College London, UK) discusses non-motor symptoms in Parkinson’s disease (PD) and the repurposing of existing medication in PD to target new areas such as cognition.
- Are objective measures available for non-motor symptoms of Parkinson’s disease (PD), similar to objective measures for motor symptoms? (0:04)
- How can existing drugs for PD be repurposed to target non-motor symptoms in PD? (2:06)
- What is the effect of advanced therapies, such as apomorphine and intrajejunal levodopa infusion, on non-motor symptoms in PD? (4:29)
View Part 1 of this expert interview here.
Speaker disclosure: Daniel van Wamelen has nothing to disclose in relation to this video interview.
Filmed at the American Academy of Neurology (AAN) Annual Meeting, Philadelphia, USA, May 2019.
Share this Video
Related Videos In Parkinson's Disease
Veronica Clark, Parkinson’s Europe: Presidential Update, and the Parkinson’s Manifesto for Europe
The European Parkinson’s Disease Association (EPDA) recently changed its name to Parkinson’s Europe. They are the only European Parkinson’s umbrella organisation and have been working with the global Parkinson’s community for nearly 30 years. As a leading voice for Parkinson’s in Europe, they provide trusted information; advance and share good practices; raise awareness and improve […]
Suman Kushwaha, MDS 2022: COVID-19 vaccine induced parkinsonism and cognitive dysfunction
Two cases of COVID-19 vaccination associated neurological symptoms were presented, with patients displaying parkinsonism and cognitive dysfunction. In this touchNEUROLOGY interview, we speak with Dr Suman Kushwaha (Institute of Human Behaviour and Allied Sciences (IHBAS), Dilshad Garden, Delhi, India) to discuss the neurological symptoms and investigations leading to the case report conclusions. The abstract entitled […]
Suman Kushwaha, MDS 2022: Neurological symptoms and COVID-19 vaccination
Neurological complications, such as peripheral neuropathy, have been associated with COVID-19 vaccination. In this touchNEUROLOGY interview, we speak with Dr Suman Kushwaha (Institute of Human Behavior and Allied Sciences (IHBAS), Dilshad Garden, Delhi, India) to discuss the neurological symptoms that have been observed. The abstract entitled ‘Covid vaccine induced parkinsonism and cognitive dysfunction’ was presented […]
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!